Related Experiment Video

Updated: Jun 10, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

A chemosensitization screen identifies TP53RK, a kinase that restrains apoptosis after mitotic stress

David Peterson1, James Lee, Xingye C Lei

  • 1Research Oncology, Genentech, Inc., South San Francisco, California, USA.

Cancer Research
|July 22, 2010
PubMed

Insights

Taxanes cause mitotic arrest, but cancer cells respond differently to apoptosis. Researchers identified TP53RK as a key factor influencing this response, potentially improving cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Taxanes are effective chemotherapeutics inducing mitotic arrest but exhibit variable clinical efficacy due to differing cancer cell apoptotic responses.
  • Understanding the molecular mechanisms of apoptosis following mitotic stress is crucial for enhancing taxane-based therapy.

Purpose of the Study:

  • To identify genes influencing apoptosis rate and extent after mitotic arrest.
  • To investigate the role of TP53RK in cancer cell response to antimitotic agents.

Main Methods:

  • Screening of a kinase-enriched small interfering RNA library.
  • Assessing caspase-3/7 activation in response to paclitaxel, a PLK1 inhibitor, and cisplatin.
  • Utilizing time-lapse microscopy to observe cellular kinetics.

Main Results:

  • Depletion of TP53RK significantly increased caspase-3/7 activation upon exposure to antimitotic agents.
  • TP53RK knockdown led to more rapid cell death after mitotic entry in the presence of paclitaxel.
  • TP53RK expression levels vary across different cancer types.

Conclusions:

  • TP53RK levels may serve as a predictive biomarker for response to antimitotic therapies.
  • Inhibiting TP53RK could potentially sensitize cancers to taxane treatment.
  • Elucidating TP53RK's role offers a pathway to improved clinical strategies for taxane-based chemotherapy.

More Related Videos

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...